119 related articles for article (PubMed ID: 1026951)
1. Observations on the "in vitro" oxidative N-demethylation of 4-(3, 3-dimethyl-1-triazeno)-imidazole-5-carboxamide (DIC, NSC 45388).
Giraldi T; Nisi C; Sava G
Pharmacol Res Commun; 1976 Feb; 8(1):25-9. PubMed ID: 1026951
[No Abstract] [Full Text] [Related]
2. Stochastic compartmental modeling of the disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
McInnis B; Kapadia A; El-Asfouri S; Loo TL
Cancer Chemother Rep; 1975; 59(4):843-5. PubMed ID: 1175174
[No Abstract] [Full Text] [Related]
3. 5-(3-Hydroxymethyl-3-methyl-1-triazeno imidazole-4-carboxamide is a metabolite of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DIC, DTIC NSC-45388).
Kolar GF; Maurer M; Wildschütte M
Cancer Lett; 1980 Sep; 10(3):235-41. PubMed ID: 7427920
[TBL] [Abstract][Full Text] [Related]
4. Microsomal metabolism of triazenylimidazoles.
Hill DL
Cancer Res; 1975 Nov; 35(11 Pt 1):3106-10. PubMed ID: 241485
[TBL] [Abstract][Full Text] [Related]
5. Investigation on the oxidative N-demethylation of aryl triazenes in vitro.
Giraldi T; Nisi C; Sava G
Biochem Pharmacol; 1975 Oct; 24(19):1793-7. PubMed ID: 1233982
[No Abstract] [Full Text] [Related]
6. Microsomal mediated metabolism of dialkylaryltriazenes. I. Demethylation of ring halogenated 3,3-dimethyl-1-phenyltriazenes.
Pool BL
J Cancer Res Clin Oncol; 1979 Apr; 93(3):215-20. PubMed ID: 468884
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
Mizuno NS; Decker RW; Zakis B
Biochem Pharmacol; 1975 Mar; 24(5):615-9. PubMed ID: 1168474
[No Abstract] [Full Text] [Related]
8. Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.
Beal DD; Skibba JL; Croft WA; Cohen SM; Bryan GT
J Natl Cancer Inst; 1975 Apr; 54(4):951-7. PubMed ID: 1127724
[TBL] [Abstract][Full Text] [Related]
9. Mutagenic activity of the dacarbazine analog p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt in bacterial cells.
Tamaro M; Dolzani L; Monti-Bragadin C; Sava G
Pharmacol Res Commun; 1986 May; 18(5):491-501. PubMed ID: 3526359
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.
Beal DD; Skibba JL; Whitnable KK; Bryan GT
Cancer Res; 1976 Aug; 36(8):2827-31. PubMed ID: 179708
[TBL] [Abstract][Full Text] [Related]
11. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
Carter SK; Friedman MA
Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317
[No Abstract] [Full Text] [Related]
12. Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.
Earl RA; Townsend LB
J Med Chem; 1979 Nov; 22(11):1422-5. PubMed ID: 533891
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH
Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102
[No Abstract] [Full Text] [Related]
14. Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue.
Mizuno NS; Humphrey EW
Cancer Chemother Rep; 1972 Aug; 56(4):465-72. PubMed ID: 5081589
[No Abstract] [Full Text] [Related]
15. Metabolism of dacarbazine by rat liver microsomes contribution of CYP1A enzymes to dacarbazine N-demethylation.
Yamagata S; Ohmori S; Suzuki N; Yoshino M; Hino M; Ishii I; Kitada M
Drug Metab Dispos; 1998 Apr; 26(4):379-82. PubMed ID: 9531528
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action and pharmacology studies with DTIC (NSC-45388).
Loo TL; Housholder GE; Gerulath AH; Saunders PH; Farquhar D
Cancer Treat Rep; 1976 Feb; 60(2):149-52. PubMed ID: 1260772
[No Abstract] [Full Text] [Related]
17. Relevance of dimethylamine to mechanism studies of DIC (DTIC, NSC 45388).
Saunders PP; Chao LY
Med Pediatr Oncol; 1976; 2(3):253-8. PubMed ID: 979914
[TBL] [Abstract][Full Text] [Related]
18. N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man.
Skibba JL; Beal DD; Ramirez G; Bryan GT
Cancer Res; 1970 Jan; 30(1):147-50. PubMed ID: 5441073
[No Abstract] [Full Text] [Related]
19. In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide.
Contessa AR; Bonmassar A; Giampietri A; Circolo A; Goldin A; Fioretti MC
Cancer Res; 1981 Jun; 41(6):2476-82. PubMed ID: 7016315
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
